Alpha-glucosidase - PDFSEARCH.IO - Document Search Engine

Alpha-glucosidase
Results: 67

#	Item
51	Microsoft Word - CRW Final Report- Screening for Pompe Disease 06042013_FinalEdits_CLEAN.docx Add to Reading List Source URL: www.hrsa.gov Language: English - Date: 2013-06-20 16:06:33 Glycogen storage disease type II Lysosomal storage disease Acid alpha-glucosidase Newborn screening Screening Hypertrophic cardiomyopathy Health Rare diseases Medicine
52	EVIDENCE REVIEW: POMPE DISEASE Add to Reading List Source URL: www.hrsa.gov Language: English - Date: 2012-01-07 00:54:21 Glycogen storage disease type II Lysosomal storage disease Acid alpha-glucosidase Newborn screening Screening Medical genetics Medicine Health Rare diseases
53	February 26, 2013 Press Release Mitsubishi Tanabe Pharma Corporation TENELIA® 20mg tablets, a Treatment for Type 2 Diabetes Mellitus Application for Partial Change in Indications for Combination Therapy Add to Reading List Source URL: www.mt-pharma.co.jp Language: English - Date: 2013-12-11 23:08:01 Health Anti-diabetic medication Biguanide Alpha-glucosidase inhibitor Dipeptidyl peptidase-4 inhibitor Hypoglycemia Insulin Diabetes Endocrine system Medicine
54	PRECOSE® (acarbose tablets[removed]DESCRIPTION PRECOSE® (acarbose tablets) is an oral alpha-glucosidase inhibitor for use in the management of type 2 diabetes mellitus. Acarbose is an oligosaccharide which is obtained f Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2012-03-01 15:12:58 Endocrinology Eli Lilly and Company Anti-diabetic drugs Blood tests Thiazolidinediones Anti-diabetic medication Acarbose Alpha-glucosidase inhibitor Metformin Endocrine system Medicine Diabetes
55	PRECOSE® (acarbose tablets[removed]DESCRIPTION PRECOSE® (acarbose tablets) is an oral alpha-glucosidase inhibitor for use in the management of type 2 diabetes mellitus. Acarbose is an oligosaccharide which is obtained fr Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-03-28 12:08:24 Endocrinology Eli Lilly and Company Anti-diabetic drugs Blood tests Thiazolidinediones Anti-diabetic medication Acarbose Alpha-glucosidase inhibitor Metformin Endocrine system Medicine Diabetes
56	LYSOSOMAL STORAGE DISORDER Quarterly Report PROFICIENCY TESTING Volume 2, No. 2 Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2013-05-21 09:46:35 Krabbe disease Lysosomal storage disease Glycogen storage disease type II Galactosylceramidase Newborn screening Association of Public Health Laboratories Acid alpha-glucosidase Centers for Disease Control and Prevention Health Rare diseases Medicine
57	LYSOSOMAL STORAGE DISORDER Quarterly Report PROFICIENCY TESTING August 2013 Add to Reading List Source URL: www.cdc.gov Language: English - Date: 2013-08-26 07:08:24 Krabbe disease Lysosomal storage disease Glycogen storage disease type II Galactosylceramidase Newborn screening Association of Public Health Laboratories Acid alpha-glucosidase Centers for Disease Control and Prevention Health Rare diseases Medicine
58	JANUARY[removed]UNDERSTANDING POMPE DISEASE Pompe (POM-pay) disease, also known as glycogen storage disease type II or acid maltase deficiency, is a Add to Reading List Source URL: www.niams.nih.gov Language: English - Date: 2013-05-22 13:44:51 Lysosomal storage diseases Glycogen storage disease type II Hepatology National Institutes of Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Acid alpha-glucosidase Alglucosidase alfa Arthritis Weakness Medicine Health Rare diseases
59	Amicus Therapeutics Announces Second Quarter 2007 Financial Results Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2011-12-11 11:39:13 Clinical research Lysosomal storage diseases Glycogen storage disease type II Hepatology Enzyme replacement therapy Acid alpha-glucosidase Clinical trial ERT Amyotrophic lateral sclerosis Health Medicine Rare diseases
60	Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease CRANBURY, N.J., June 3, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company Add to Reading List Source URL: www.unitedpompe.com Language: English - Date: 2008-06-03 09:27:22 Lysosomal storage diseases Glycogen storage disease type II Hepatology Motor neurone disease Acid alpha-glucosidase Amyotrophic lateral sclerosis Clinical trial Molecular chaperone therapy Health Rare diseases Medicine

UPDATE